1-Hexylcarbamoyl-5-fluorouracil alters the expression of heat shock protein in HeLa cells

Anticancer Drugs. 1991 Feb;2(1):45-8. doi: 10.1097/00001813-199102000-00006.

Abstract

We determined the effect of 1-hexylcarbamoyl-5-fluorouracil (HCFU), a masked compound of 5-fluorouracil, on the expression of heat shock protein (HSP) in heat-treated HeLa cells. We used a monoclonal anti-72-kDa heat shock protein antibody. At 37 degrees C, HSP was predominant in the cytoplasm of cells and heating to 43 degrees C for 30 min increased the synthesis of HSP in the nucleus. When HeLa cells were treated with heat and HCFU, at a concentration which showed evidence of synergy, nuclear staining of the cells decreased. Thus, the altered expression of HSP by HCFU is related to a synergism between heat and HCFU.

MeSH terms

  • Cells, Cultured
  • Clone Cells / drug effects
  • Clone Cells / metabolism
  • Fluorouracil / analogs & derivatives*
  • Fluorouracil / pharmacology
  • HeLa Cells
  • Heat-Shock Proteins / biosynthesis*
  • Heat-Shock Proteins / drug effects
  • Heat-Shock Proteins / physiology
  • Humans
  • Immunohistochemistry
  • Stem Cells / drug effects

Substances

  • Heat-Shock Proteins
  • carmofur
  • Fluorouracil